GO:0002946 tRNA C5-cytosine methylation: Epitranscriptomic Mark, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002946 (tRNA C5-cytosine methylation) describes the enzymatic addition of a methyl group to carbon 5 of cytosine in tRNA, producing 5-methylcytosine (m5C).
• RNA (C5-cytosine) methyltransferases are the enzymes that catalyze this modification, using S-adenosyl-L-methionine (SAM) as the methyl donor.
• m5C in tRNA contributes to tRNA stability, translational fidelity, and cellular stress responses, and its dysregulation is linked to neurocognitive disorders.
• The catalytic mechanism involves base flipping and conserved aromatic residues, as demonstrated in related DNA methyltransferases.
• Dysregulation of RNA modification systems, including m5C writers, is observed in clinical populations with neurocognitive disorders.
• Studying GO:0002946 requires integrating CRISPR knockout, point-mutation, and knock-in models with RNA-seq, Ribo-seq, and mass spectrometry [1,2].
Description
tRNA C5-cytosine methylation (GO:0002946) is the biological process in which a cytosine residue within a transfer RNA (tRNA) molecule is methylated at position 5 of the cytosine ring, yielding 5-methylcytosine (m5C). This post-transcriptional modification is catalyzed by RNA (C5-cytosine) methyltransferases, a family of enzymes that transfer a methyl group from S-adenosyl-L-methionine (SAM) to the cytosine base. The modification is conserved across all domains of life and plays critical roles in tRNA structure, stability, and function. Researchers study GO:0002946 to understand how epitranscriptomic marks regulate translation and how their perturbation contributes to human disease. The process is mechanistically related to other base-flipping methyltransferases, where conserved aromatic residues facilitate nucleotide flipping and catalysis.
tRNA C5-cytosine methylation At A Glance
| GO ID | GO:0002946 |
|---|---|
| GO term | tRNA C5-cytosine methylation |
| Ontology | biological_process |
| Synonym | tRNA 5-methylcytosine biosynthesis |
| Major function | Enzymatic methylation of cytosine at position 5 in tRNA, producing m5C |
| Enzyme class | RNA (C5-cytosine) methyltransferases |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor |
| Mechanistic feature | Base flipping and conserved aromatic residues in the catalytic pocket |
| Disease relevance | Dysregulation of RNA modification systems in neurocognitive disorders |
What Is GO:0002946?
GO:0002946, tRNA C5-cytosine methylation, is defined as the process whereby a cytosine in a tRNA is methylated at position 5 of the cytosine. This enzymatic modification converts cytosine to 5-methylcytosine (m5C) within tRNA molecules, a post-transcriptional event that alters the chemical properties of the tRNA and influences its interactions with the translational machinery.
Why Is tRNA C5-cytosine methylation Important in Cell Biology?
tRNA C5-cytosine methylation (GO:0002946) is important because m5C modifications in tRNA affect tRNA stability, folding, and decoding capacity, thereby influencing global protein synthesis. Dysregulation of RNA modification systems, including m5C writers, has been observed in clinical populations with neurocognitive disorders, suggesting that perturbations in this process may contribute to disease pathogenesis. Understanding the enzymatic mechanism, which involves base flipping and conserved aromatic residues, provides a framework for targeting these enzymes in therapeutic development.
• m5C in tRNA enhances tRNA stability and prevents degradation under stress conditions.
• The modification influences translational fidelity and codon-anticodon interactions.
• RNA (C5-cytosine) methyltransferases are conserved across species, making them tractable for comparative studies.
• Dysregulation of RNA modification systems is linked to neurocognitive disorders in clinical populations.
• Base-flipping mechanisms are shared with DNA methyltransferases, offering mechanistic insights.
• m5C writers are potential therapeutic targets for diseases involving translational dysfunction [1,2].
• Studying GO:0002946 helps elucidate epitranscriptomic regulation of gene expression.
• CRISPR-based models enable causal testing of m5C writer genes in disease contexts [1,2].
• Mass spectrometry and sequencing methods allow quantitative mapping of m5C in tRNA.
• Understanding tRNA modification pathways can inform ribosomopathy and neurodegeneration research.
What Happens During tRNA C5-cytosine methylation?
Recognition and Binding of tRNA Substrate
In simple terms: The enzyme finds and grabs the tRNA molecule that needs modification.
RNA (C5-cytosine) methyltransferases specifically recognize target tRNAs through structural features, including the anticodon loop and overall L-shaped tRNA architecture. Binding involves interactions with conserved nucleotides and may require accessory proteins for optimal specificity. The enzyme-substrate complex positions the target cytosine for chemical modification.
Base Flipping and Active-Site Engagement
In simple terms: The target cytosine is flipped out of the tRNA helix so the enzyme can reach it.
Base flipping is a conserved mechanism in methyltransferases, where the target nucleotide is rotated out of the helical stack into the enzyme active site. Conserved aromatic amino acid residues at motifs IV and VIII facilitate this flipping and stabilize the extrahelical base. This step is critical for exposing the C5 position of cytosine to the catalytic center.
Methyl Group Transfer from SAM
In simple terms: The enzyme transfers a methyl group from SAM onto the cytosine.
The methyltransferase catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to the C5 position of cytosine, forming 5-methylcytosine (m5C). This reaction proceeds through a nucleophilic attack mechanism involving conserved catalytic residues. SAM is converted to S-adenosyl-L-homocysteine (SAH) as a byproduct.
Product Release and tRNA Maturation
In simple terms: The modified tRNA is released and continues its journey in the cell.
After methylation, the m5C-modified tRNA is released from the enzyme and can participate in translation. The modification may enhance tRNA stability and folding, contributing to its maturation and function. Dysregulation of this step can lead to altered tRNA pools and translational defects.
Key Genes Involved in GO:0002946 tRNA C5-cytosine methylation
The following genes and proteins are involved in tRNA C5-cytosine methylation (GO:0002946) or related RNA modification pathways, based on published literature [1,2,3].
| Gene | Major Role | Research Relevance |
|---|---|---|
| NSUN2 | RNA (C5-cytosine) methyltransferase that catalyzes m5C in tRNA | Implicated in neurodevelopmental disorders and cancer |
| NSUN3 | Mitochondrial RNA methyltransferase for m5C in tRNA | Linked to mitochondrial translation defects |
| NSUN6 | tRNA m5C methyltransferase targeting specific tRNAs | Studied for substrate specificity |
| DNMT2 | tRNA aspartic acid methyltransferase (m5C) in some organisms | Model for base-flipping mechanism [1,3] |
| TRMT2A | tRNA m5C methyltransferase in yeast and humans | Potential role in tRNA stability |
| ALKBH1 | tRNA demethylase that removes m5C | Counteracts methylation, affecting tRNA function |
| TET2 | RNA demethylase for m5C in some contexts | Cross-talk with DNA methylation pathways |
| METTL3 | m6A methyltransferase, not m5C, but part of RNA modification network | Comparative studies of RNA modifications |
| FTO | RNA demethylase for m6A, not m5C, but relevant to epitranscriptomics | Indirect regulation of RNA modification balance |
| ALKBH3 | RNA demethylase for m1A and m3C, not m5C | Related RNA repair pathways |
| NSUN4 | Mitochondrial rRNA methyltransferase | Mitochondrial gene expression |
| NSUN5 | rRNA methyltransferase | Ribosome biogenesis |
| NSUN7 | Potential RNA methyltransferase | Understudied family member |
| TRDMT1 | tRNA methyltransferase in some species | Homolog of DNMT2 |
| SAM synthetase (MAT2A) | Produces SAM, the methyl donor | Metabolic regulation of methylation |
| SAHH (AHCY) | Hydrolyzes SAH to maintain methylation flux | Regulates methyltransferase activity |
| Mettl1 | tRNA m7G methyltransferase, not m5C, but co-regulates tRNA modifications | Network analysis |
How Is tRNA C5-cytosine methylation Regulated?
The process of tRNA C5-cytosine methylation (GO:0002946) is regulated at multiple levels, including enzyme expression, substrate availability, and metabolic flux of the methyl donor SAM. Dysregulation of RNA modification systems, including m5C writers, has been observed in clinical populations with neurocognitive disorders, suggesting that disease-associated factors may perturb this process. The catalytic activity of methyltransferases can be influenced by conserved aromatic residues that affect base flipping and catalysis, as shown for related enzymes.
tRNA C5-cytosine methylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NSUN2 | Neurodevelopmental disorders, cancer | CRISPR knockout in neuronal cell lines [1,2] |
| NSUN3 | Mitochondrial translation defects | Point-mutation knock-in in HEK293T |
| DNMT2 | Stress response, tRNA stability | Overexpression in HeLa cells [1,3] |
| ALKBH1 | tRNA demethylation, neurological phenotypes | Knockout in mouse models |
| TRMT2A | tRNA modification in yeast and human cells | Knock-in of tagged enzyme |
Neurocognitive Disorders
Dysregulation of RNA modification systems, including m5C methylation, has been reported in clinical populations with neurocognitive disorders. Alterations in tRNA modification enzymes may contribute to translational deficits and neuronal dysfunction. Studying GO:0002946 in patient-derived models could reveal causal mechanisms.
Cancer
RNA (C5-cytosine) methyltransferases such as NSUN2 are often overexpressed in cancers and correlate with poor prognosis. m5C modifications in tRNA can promote oncogenic translation and cancer cell survival. Targeting these enzymes is a potential therapeutic strategy.
Mitochondrial Diseases
NSUN3-mediated m5C in mitochondrial tRNA is essential for mitochondrial translation. Defects in this pathway can lead to mitochondrial dysfunction and associated diseases. Model systems with NSUN3 mutations help dissect these mechanisms.
From tRNA C5-cytosine methylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NSUN2 affect tRNA m5C levels? | CRISPR knockout in HEK293T cells |
| Does a point mutation in the catalytic site abolish methyltransferase activity? | Point-mutation knock-in of NSUN2 [1,3] |
| Can tagged NSUN2 rescue m5C defects? | Knock-in of FLAG-tagged NSUN2 |
| Does overexpression of NSUN2 alter translation? | Overexpression in cancer cell lines |
| Which tRNAs are targeted by NSUN6? | Knockout and RNA-seq in HeLa cells |
| Does ALKBH1 demethylation affect tRNA stability? | Knockout in mouse embryonic fibroblasts |
How to Study the tRNA C5-cytosine methylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA bisulfite sequencing | m5C sites in tRNA | Mapping methylation changes after knockout |
| LC-MS/MS | Quantitative m5C levels | Validating methyltransferase activity |
| Ribo-seq | Translation efficiency and ribosome pausing | Linking m5C to protein synthesis |
| CRISPR knockout screens | Gene essentiality and pathway interactions | Discovering regulators of tRNA methylation |
| Western blot | Protein expression of methyltransferases | Validating knockout or overexpression |
| Immunofluorescence | Subcellular localization of enzymes | Assessing mitochondrial vs cytoplasmic localization |
| qRT-PCR | tRNA levels and splicing | Measuring tRNA stability |
| In vitro methyltransferase assay | Enzymatic activity with SAM | Testing point mutants [1,3] |
RNA Sequencing and m5C Mapping
RNA-seq combined with bisulfite treatment or m5C-specific antibodies can map m5C sites in tRNA at single-nucleotide resolution. These methods quantify changes in methylation upon genetic perturbation. They are essential for validating GO:0002946 activity in cells.
Mass Spectrometry
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) can directly quantify m5C levels in purified tRNA. This method provides stoichiometric information and is complementary to sequencing. It is used to validate methyltransferase activity in vitro and in vivo.
Ribosome Profiling (Ribo-seq)
Ribo-seq measures translation efficiency and codon occupancy, revealing how m5C changes affect protein synthesis. It can detect ribosome pausing at codons dependent on modified tRNAs. This method links GO:0002946 to translational output.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout screens can identify genes required for tRNA methylation and cellular fitness. These screens uncover synthetic lethal interactions with m5C pathway components. They are powerful for discovering novel regulators of GO:0002946.
How CRISPR Can Be Used to Study GO:0002946 tRNA C5-cytosine methylation
Knockout
CRISPR knockout of RNA (C5-cytosine) methyltransferase genes such as NSUN2 or NSUN3 eliminates m5C deposition in target tRNAs. These models are used to assess the impact on translation, cell growth, and stress responses. Knockout cell lines serve as negative controls for m5C detection assays.
Point Mutation
Point mutations in catalytic residues of methyltransferases, such as those in motif IV or VIII, can abolish base flipping and methylation activity. CRISPR-mediated point-mutation knock-in allows precise testing of these residues in cells [1,3]. Such models distinguish catalytic activity from scaffolding functions.
Knock-in
Knock-in of tagged methyltransferases (e.g., FLAG, HA) enables affinity purification and localization studies. Knock-in of disease-associated mutations can model patient-specific defects in tRNA methylation [1,2]. These models are valuable for drug screening and mechanistic studies.
Overexpression
Overexpression of wild-type or mutant methyltransferases can elevate m5C levels and drive oncogenic translation. These models are used to study gain-of-function effects in cancer and neurodegeneration [1,2]. They complement knockout studies by revealing dosage-sensitive phenotypes.
How EDITGENE Supports tRNA C5-cytosine methylation Research
Researchers studying tRNA C5-cytosine methylation-related genes often need to determine whether a candidate gene is causally involved in m5C deposition, tRNA stability, or disease phenotypes. EDITGENE provides CRISPR-based cell model services to enable such causal experiments with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for tRNA C5-cytosine methylation research.
Frequently Asked Questions About tRNA C5-cytosine methylation
What is tRNA C5-cytosine methylation?
tRNA C5-cytosine methylation (GO:0002946) is the enzymatic addition of a methyl group to carbon 5 of cytosine in tRNA, forming 5-methylcytosine (m5C).
What genes are involved in tRNA C5-cytosine methylation?
Key genes include NSUN2, NSUN3, NSUN6, DNMT2, and TRMT2A, which encode RNA (C5-cytosine) methyltransferases.
What is the function of m5C in tRNA?
m5C in tRNA enhances tRNA stability, folding, and translational fidelity, and influences stress responses.
How is tRNA C5-cytosine methylation regulated?
It is regulated by enzyme expression, SAM availability, and metabolic flux, with dysregulation observed in neurocognitive disorders [1,2].
What diseases are associated with tRNA C5-cytosine methylation?
Dysregulation is linked to neurocognitive disorders, cancer, and mitochondrial diseases [1,2].
What methods are used to study tRNA C5-cytosine methylation?
Methods include RNA bisulfite sequencing, LC-MS/MS, Ribo-seq, and CRISPR screens.
What is the mechanism of base flipping in methyltransferases?
Base flipping involves rotation of the target cytosine out of the helix, facilitated by conserved aromatic residues.
Can CRISPR be used to study tRNA C5-cytosine methylation?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal studies of m5C writers [1,2].
What is the role of NSUN2 in tRNA methylation?
NSUN2 catalyzes m5C in tRNA and is implicated in neurodevelopmental disorders and cancer.
How does m5C affect translation?
m5C modulates tRNA stability and codon-anticodon interactions, affecting translation efficiency and fidelity.
Conclusion
tRNA C5-cytosine methylation (GO:0002946) is a conserved epitranscriptomic process that modifies tRNA to regulate stability and translation. Its dysregulation is linked to neurocognitive disorders and cancer, making it a compelling target for mechanistic and therapeutic research [1,2]. CRISPR-based models and advanced sequencing methods provide powerful tools to dissect this pathway and its disease relevance [1,2,3].
References
- 1. Kuznetsova SA et al.. 2019. RNA (C5-cytosine) Methyltransferases.. Biochemistry (Mosc) 84(8):851-869 PMID: 31522668
- 2. Knight HM et al.. 2024. Dysregulation of RNA modification systems in clinical populations with neurocognitive disorders.. Neural Regen Res 19(6):1256-1261 PMID: 37905873
- 3. Pues H et al.. 1999. Functional roles of the conserved aromatic amino acid residues at position 108 (motif IV) and position 196 (motif VIII) in base flipping and catalysis by the N6-adenine DNA methyltransferase from Thermus aquaticus.. Biochemistry 38(5):1426-34 PMID: 9931007
